Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$428K Buy
+9,441
New +$413K 0.02% 444
2021
Q1
Sell
-6,286
Closed -$274K 1305
2020
Q4
$274K Buy
6,286
+649
+12% +$25.6K 0.01% 740
2020
Q3
$219K Buy
5,637
+305
+6% +$13.4K 0.01% 567
2020
Q2
$231K Sell
5,332
-670
-11% -$25.4K 0.01% 446
2020
Q1
$200K Buy
+6,002
New +$217K 0.01% 303

Other funds holding SRDX

IndexIQ Advisors's SRDX Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Surmodics (SRDX) in Q1 2022: 9,441 shares worth $428K. The stake represents 0.02% of the portfolio and ranks #444 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in SRDX as recently as Q4 2020.

IndexIQ Advisors first reported a position in SRDX in Q1 2020 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2022.

  • IndexIQ Advisors held 9,441 shares of Surmodics worth $428K as of Q1 2022.
  • Surmodics was a new IndexIQ Advisors position in Q1 2022.
  • Surmodics made up 0.02% of IndexIQ Advisors's portfolio in Q1 2022, its #444 holding.
  • IndexIQ Advisors first reported a position in Surmodics in Q1 2020 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.